Heqettherapeutics

1 known investors

Heqet Therapeutics is a pre-clinical stage biotech developing non-coding RNA-based therapies for cardiovascular diseases, with a focus on acute myocardial infarction. Its compounds target multiple pathways through the upregulation of certain non-coding RNAs to promote heart regeneration.